Inhibition of IKKε by pharmacological treatment with the drug amlexanox or a knockout in mice resulted in enhanced insulin sensitivity, glucose tolerance, and improvement of fatty liver symptoms, which has been linked to elevated energy expenditure, diminished inflammation, and augmented catecholamine sensitivity [30,31,32]. The gene discussed is IKBKE; the disease is fatty liver disease.